These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 21128354)

  • 1. Unique approach to HIV research in drug users. Developer warns it's not answer for every study.
    AIDS Alert; 2010 Nov; 25(11):128-9. PubMed ID: 21128354
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV & IV drug users and hepatitis "C".
    Kimbrough M
    Women Alive; 2000; ():9. PubMed ID: 11693099
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential cofactors in the outcomes of HIV infection in intravenous drug users.
    Des Jarlais DC
    NIDA Res Monogr; 1991; 109():115-23. PubMed ID: 1753988
    [No Abstract]   [Full Text] [Related]  

  • 4. Harm reduction: a realistic approach toward injection drug users.
    Mattinson K; Hawthorne J
    Can Nurse; 1996 Feb; 92(2):22-6. PubMed ID: 9147802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment. Injection drug users have poor access to HIV care, study finds.
    AIDS Policy Law; 2010 Apr; 25(5):3. PubMed ID: 20564805
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 infection detected by polymerase chain reaction frequently precedes antibody seroconversion in drug users.
    Bruisten SM; Mientjes GH; van Delft P; de Wolf F; van Ameijden EJ; Cornelissen M; Goudsmit J; Coutinho RA; Huisman JG
    AIDS; 1994 Dec; 8(12):1736-7. PubMed ID: 7888127
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relatively low HIV prevalence among drug users in The Hague in spite of risky injection behavior].
    de Haan HA; van den Hoek JA; van Haastrecht HJ; van der Meer CW; Coutinho RA
    Ned Tijdschr Geneeskd; 1991 Feb; 135(6):218-21. PubMed ID: 2005985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence and seroincidence of HIV-1 in injection drug users using the VA system.
    Hartigan PM; Hamilton JD
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S215-7. PubMed ID: 7865304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factors facilitating changes in HIV risk behavior in parenteral drug users].
    Peri JM; Soltó C; Bayés R
    Med Clin (Barc); 1994 Feb; 102(6):237-8. PubMed ID: 8159063
    [No Abstract]   [Full Text] [Related]  

  • 10. An analysis of the effects of HIV infection in a cohort of intravenous drug users.
    O'Kelly FD; Bury G
    Ir Med J; 1996; 89(3):112-4. PubMed ID: 8707519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum B2-microglobulin and human immunodeficiency virus infection in intravenous drug users: a cross-sectional study.
    De Mercato R; Rezza G; Giuliani M; Perna E; Iovinella V; Bassi A; Tagliaferro R
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):447-8. PubMed ID: 2152304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid TB prophylaxis effective in drug users with HIV.
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of HIV infection among drug users in Zuid-Limburg].
    Wiessing LG; Houweling H; Meulders WA; Cerdá E; Jansen M; Sprenger MJ
    Ned Tijdschr Geneeskd; 1995 Sep; 139(38):1936-40. PubMed ID: 7477534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and injecting drug users: from epidemiology to public health.
    Wodak A; Moss A
    AIDS; 1990; 4 Suppl 1():S105-9. PubMed ID: 2152552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous drug users and the HIV epidemic].
    Skretting A
    Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1981-4. PubMed ID: 1509465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The practice of 'frontloading' among intravenous drug users: association with HIV-antibody.
    Samuels JF; Vlahov D; Anthony JC; Solomon L; Celentano DD
    AIDS; 1991 Mar; 5(3):343. PubMed ID: 2059379
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hepatitis C in intravenous drug users].
    Filoche B
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B252-6. PubMed ID: 12180298
    [No Abstract]   [Full Text] [Related]  

  • 19. Learning from HIV epidemics among injecting drug users.
    Jarlais DC
    Int J Drug Policy; 2010 Mar; 21(2):97-9. PubMed ID: 20018500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users.
    Wu N; Li D; Zhu B; Zou W
    Chin Med J (Engl); 2003 Sep; 116(9):1318-20. PubMed ID: 14527356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.